Published in Appl Microbiol Biotechnol on November 13, 2008
Carbohydrate metabolism in Bifidobacteria. Genes Nutr (2011) 1.50
Diversity, ecology and intestinal function of bifidobacteria. Microb Cell Fact (2014) 1.35
Development of a double-crossover markerless gene deletion system in Bifidobacterium longum: functional analysis of the α-galactosidase gene for raffinose assimilation. Appl Environ Microbiol (2012) 0.99
Metabolism of four α-glycosidic linkage-containing oligosaccharides by Bifidobacterium breve UCC2003. Appl Environ Microbiol (2013) 0.87
Mutations and genomic islands can explain the strain dependency of sugar utilization in 21 strains of Propionibacterium freudenreichii. BMC Genomics (2015) 0.86
α-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway. J Biol Chem (2011) 0.85
α-Galactosidase/sucrose kinase (AgaSK), a novel bifunctional enzyme from the human microbiome coupling galactosidase and kinase activities. J Biol Chem (2011) 0.83
Partial Characterization of α-Galactosidic Activity from the Antarctic Bacterial Isolate, Paenibacillus sp. LX-20 as a Potential Feed Enzyme Source. Asian-Australas J Anim Sci (2012) 0.76
Uncommon Glycosidases for the Enzymatic Preparation of Glycosides. Biomolecules (2015) 0.75
Stereochemical course of hydrolytic reaction catalyzed by alpha-galactosidase from cold adaptable marine bacterium of genus Pseudoalteromonas. Front Chem (2014) 0.75
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol (2005) 2.18
New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol (2003) 1.88
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother (2010) 1.79
Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res (2009) 1.57
Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol (2002) 1.56
Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol (2005) 1.50
Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays. Appl Environ Microbiol (2007) 1.48
Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med (2012) 1.45
PASSCLAIM--gut health and immunity. Eur J Nutr (2004) 1.43
Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol (2002) 1.41
Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol (2004) 1.37
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr (2008) 1.34
Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr (2007) 1.34
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol (2009) 1.28
Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr (2002) 1.27
Microencapsulation of probiotics for gastrointestinal delivery. J Control Release (2012) 1.25
Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med (2004) 1.19
A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr (2010) 1.18
Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr (2012) 1.17
A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr (2013) 1.16
Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr Issues Intest Microbiol (2003) 1.15
An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol (2003) 1.15
Variation in antibiotic-induced microbial recolonization impacts on the host metabolic phenotypes of rats. J Proteome Res (2011) 1.13
Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res (2012) 1.11
Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr (2007) 1.11
Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr (2010) 1.11
In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol Ecol (2002) 1.08
Differences in rDNA libraries of faecal bacteria derived from 10- and 25-cycle PCRs. Int J Syst Evol Microbiol (2002) 1.07
Prebiotic capacity of inulin-type fructans. J Nutr (2007) 1.05
Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des (2009) 1.05
Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr (2008) 1.02
Pectin and pectic-oligosaccharides induce apoptosis in in vitro human colonic adenocarcinoma cells. Anticancer Res (2003) 0.99
Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci (2014) 0.98
A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr (2011) 0.98
Carbohydrate preference, acid tolerance and bile tolerance in five strains of Bifidobacterium. J Appl Microbiol (2006) 0.98
Probiotics and prebiotics in infant nutrition. Proc Nutr Soc (2007) 0.97
In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids. Anaerobe (2012) 0.97
In vitro fermentation of carbohydrates by porcine faecal inocula and their influence on Salmonella Typhimurium growth in batch culture systems. FEMS Microbiol Ecol (2008) 0.97
Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal. Nutrition (2012) 0.96
Effects of bovine alpha-lactalbumin and casein glycomacropeptide-enriched infant formulae on faecal microbiota in healthy term infants. J Pediatr Gastroenterol Nutr (2006) 0.95
Sutterella stercoricanis sp. nov., isolated from canine faeces. Int J Syst Evol Microbiol (2004) 0.95
The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol (2010) 0.95
The influence of Staphylococcus aureus on gut microbial ecology in an in vitro continuous culture human colonic model system. PLoS One (2011) 0.94
Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J Pediatr (2009) 0.94
A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol (2009) 0.94
Purified galactooligosaccharide, derived from a mixture produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium adhesion and invasion in vitro and in vivo. J Med Microbiol (2010) 0.93
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) (2014) 0.93
In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota. FEMS Microbiol Ecol (2008) 0.93
Molecular cloning and comparative analysis of four beta-galactosidase genes from Bifidobacterium bifidum NCIMB41171. Appl Microbiol Biotechnol (2007) 0.92
In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J Agric Food Chem (2005) 0.92
Influence of disaccharide structure on prebiotic selectivity in vitro. J Agric Food Chem (2005) 0.91
Synbiotics in health and disease. Annu Rev Food Sci Technol (2011) 0.90
An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities. Anaerobe (2004) 0.90
Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr Issues Intest Microbiol (2004) 0.90
Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br J Nutr (2011) 0.90
Metabolism of Maillard reaction products by the human gut microbiota--implications for health. Mol Nutr Food Res (2006) 0.89
Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl Environ Microbiol (2004) 0.88
In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites. FEMS Microbiol Ecol (2012) 0.88
In vitro fermentation of potential prebiotic flours from natural sources: impact on the human colonic microbiota and metabolome. Mol Nutr Food Res (2012) 0.87
Synthesis of prebiotic galactooligosaccharides using whole cells of a novel strain, Bifidobacterium bifidum NCIMB 41171. Appl Microbiol Biotechnol (2005) 0.87
Investigation of the faecal microbiota associated with canine chronic diarrhoea. FEMS Microbiol Ecol (2009) 0.87
Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int (2013) 0.87
Comparative analysis of four beta-galactosidases from Bifidobacterium bifidum NCIMB41171: purification and biochemical characterisation. Appl Microbiol Biotechnol (2008) 0.87
Patient doses from noncardiac diagnostic and therapeutic interventional procedures. J Vasc Interv Radiol (2006) 0.86
Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe (2002) 0.86
rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr (2003) 0.86
The effect of processing on chlorogenic acid content of commercially available coffee. Food Chem (2013) 0.86
Expression of four beta-galactosidases from Bifidobacterium bifidum NCIMB41171 and their contribution on the hydrolysis and synthesis of galactooligosaccharides. Appl Microbiol Biotechnol (2009) 0.85
Clostridium colicanis sp. nov., from canine faeces. Int J Syst Evol Microbiol (2003) 0.85
In vitro fermentation of commercial α-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Br J Nutr (2012) 0.85
In vitro fermentation of NUTRIOSE(®) FB06, a wheat dextrin soluble fibre, in a continuous culture human colonic model system. PLoS One (2013) 0.85
Evaluation of the inclusion of a mixture of organic acids or lactulose into the feed of pigs experimentally challenged with Salmonella Typhimurium. Vet Microbiol (2009) 0.84
Investigation of the faecal microbiota of kittens: monitoring bacterial succession and effect of diet. FEMS Microbiol Ecol (2011) 0.84
Differential effects of two fermentable carbohydrates on central appetite regulation and body composition. PLoS One (2012) 0.84
In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota. Appl Environ Microbiol (2011) 0.84
In vitro effects of selected synbiotics on the human faecal microbiota composition. FEMS Microbiol Ecol (2008) 0.84
BbgIV Is an Important Bifidobacterium β-Galactosidase for the Synthesis of Prebiotic Galactooligosaccharides at High Temperatures. J Agric Food Chem (2012) 0.83
A comprehensive investigation of the synthesis of prebiotic galactooligosaccharides by whole cells of Bifidobacterium bifidum NCIMB 41171. J Biotechnol (2010) 0.83
Galactooligosaccharides (GOS) inhibit Vibrio cholerae toxin binding to its GM1 receptor. J Agric Food Chem (2009) 0.83
Production and evaluation of dry alginate-chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria. Biomacromolecules (2011) 0.83
Effect of prebiotics on the human gut microbiota of elderly persons. Gut Microbes (2012) 0.82
Developing a quantitative approach for determining the in vitro prebiotic potential of dietary oligosaccharides. FEMS Microbiol Lett (2004) 0.82
Pectins and pectic-oligosaccharides inhibit Escherichia coli O157:H7 Shiga toxin as directed towards the human colonic cell line HT29. FEMS Microbiol Lett (2003) 0.82
Mixed culture fermentation studies on the effects of synbiotics on the human intestinal pathogens Campylobacter jejuni and Escherichia coli. Anaerobe (2003) 0.82
Biodiversity of human faecal bacteria isolated from phytic acid enriched chemostat fermenters. Curr Issues Intest Microbiol (2004) 0.81
Effects of resistant starch type III polymorphs on human colon microbiota and short chain fatty acids in human gut models. J Agric Food Chem (2008) 0.81